Modern Rheumatology

Papers
(The H4-Index of Modern Rheumatology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Challenges in diagnosing COVID-19 related disease in pediatric patients with rheumatic disease68
Subjective symptoms contributing to the quality of life of rheumatoid arthritis patients with clinical remission from the IORRA database32
Correction to: Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study28
Dapagliflozin for rheumatic musculoskeletal disease in patients with chronic kidney disease24
Management of patients with inflammatory rheumatic diseases after treatment failure with a first tumour necrosis factor inhibitor: A narrative review23
Correction to: Expert perspectives on pathological findings in vasculitis22
Hydroxychloroquine versus tacrolimus for the treatment of persistently active systemic lupus erythematosus21
Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: A single-centre, cross-sectional study19
Japanese version of Patient-Rated Elbow Evaluation is a useful outcome measure that potentially reflects hand function in patients with rheumatoid arthritis who underwent total elbow arthroplasty18
Should we reconsider the definition of elderly-onset rheumatoid arthritis in an ageing society?18
The impact of the COVID-19 pandemic on SLE17
Safety and effectiveness of denosumab in Japanese patients with rheumatoid arthritis: A 2-year post-marketing surveillance study16
Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study16
Role of rituximab in the treatment of systemic sclerosis: A literature review16
Diagnostic challenge of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome in pediatric age: A monocentric case series15
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: A 48-week interim analysis of the MARS study15
0.15977597236633